The observed rise in glycosylated PON1 in HCC might be attributed to the upregulation of corresponding glycosyl transferases, potentially linked to cancer-induced lipid metabolism disorder and a potential impairment in the anti-lipid peroxidase and anti-oxi radical abilities of PON1 [25]. The gene discussed is PON1; the disease is cancer.